Last reviewed · How we verify

methylprednisolone and prednisone — Competitive Intelligence Brief

methylprednisolone and prednisone (methylprednisolone and prednisone) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Corticosteroid (glucocorticoid). Area: Immunology / Rheumatology / General inflammation.

phase 3 Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR) Immunology / Rheumatology / General inflammation Small molecule Live · refreshed every 30 min

Target snapshot

methylprednisolone and prednisone (methylprednisolone and prednisone) — Astellas Pharma Inc. Methylprednisolone and prednisone are corticosteroids that suppress the immune system and reduce inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
methylprednisolone and prednisone TARGET methylprednisolone and prednisone Astellas Pharma Inc phase 3 Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
Celestone + Celestone Celestone + Celestone McMaster University marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
Oral prednisolone Taper Oral prednisolone Taper Berinstein, Jeffrey marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
Prednisone 6 weeks Prednisone 6 weeks Xinqiao Hospital of Chongqing marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
Prednisolone, prednisone, or methylprednisolone Prednisolone, prednisone, or methylprednisolone Children's Hospital of Philadelphia marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
methylprednisolone PO methylprednisolone PO Rennes University Hospital marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
Prednisone Taper Prednisone Taper Shilpa Grover, MD, MPH marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Corticosteroid (glucocorticoid) class)

  1. Assistance Publique - Hôpitaux de Paris · 3 drugs in this class
  2. Astellas Pharma Inc · 2 drugs in this class
  3. Sanofi · 2 drugs in this class
  4. Xinqiao Hospital of Chongqing · 2 drugs in this class
  5. Berinstein, Jeffrey · 2 drugs in this class
  6. Ain Shams University · 2 drugs in this class
  7. Children's Hospital of Philadelphia · 1 drug in this class
  8. Celgene · 1 drug in this class
  9. Hamilton Health Sciences Corporation · 1 drug in this class
  10. Erasme University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). methylprednisolone and prednisone — Competitive Intelligence Brief. https://druglandscape.com/ci/methylprednisolone-and-prednisone. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: